Anti‐SARS‐CoV‐2 IgG antibody levels among Thai healthcare providers receiving homologous and heterologous COVID‐19 vaccination regimens

BACKGROUND: We examined SARS‐CoV‐2 anti‐spike 1 IgG antibody levels following COVID‐19 vaccination (AstraZeneca [AZ], Sinovac [SV], Pfizer‐BioNTech [PZ]) among Thai healthcare providers. METHODS: Blood specimens were tested using enzyme‐linked immunosorbent assay. We analyzed seven vaccination regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittikraisak, Wanitchaya, Hunsawong, Taweewun, Punjasamanvong, Somsak, Wongrapee, Thanapat, Suttha, Patama, Piyaraj, Phunlerd, Leepiyasakulchai, Chaniya, Tanathitikorn, Chuleeekorn, Yoocharoen, Pornsak, Jones, Anthony R., Mongkolsirichaikul, Duangrat, Westercamp, Matthew, Azziz‐Baumgartner, Eduardo, Mott, Joshua A., Chottanapund, Suthat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111827/
https://www.ncbi.nlm.nih.gov/pubmed/35199966
http://dx.doi.org/10.1111/irv.12975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111827/
https://www.ncbi.nlm.nih.gov/pubmed/35199966
http://dx.doi.org/10.1111/irv.12975

Ejemplares similares